Named on one round in the feed.
Since 2020-03-17
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Circle Pharma A biopharmaceutical company advancing CID-165 for ER-positive breast cancer | Series B Published on thinner evidence, 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $45M | 2020-03-17 | [ PART ] |